{"schema_version":"secwatch.filing_event.v1","accession":"0001828318-23-000202","form_type":"8-K","ticker":"ENVX","cik":"0001828318","company_name":"Enovix Corp","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.807377+00:00","generated_at":"2026-06-08T17:05:10.726592+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Enovix Q3 revenue $0.2M; cash $371.3M; narrows FY2023 cash use guidance to $110M","bullets":["Q3 revenue $0.2M from U.S. Army cells; GAAP cost of revenue $16.8M; GAAP op. expenses $33.8M.","Cash, equivalents, and short-term investments $371.3M; Q3 operating cash use $28.2M; capex $17.3M.","FY2023 operational cash use forecast lowered to $110M (from $120M); capex to $65M (from $70M).","Completed FAT for one Gen2 production zone; expects all four zones FAT by Jan 2024; first samples by Apr 2024.","Acquired Routejade for electrode coating; Fab1 restructuring reduces annualized cash burn ~$22M."],"urls":{"canonical":"https://secwatch.observer/filing/0001828318-23-000202","json":"https://secwatch.observer/filing/0001828318-23-000202.json","markdown":"https://secwatch.observer/filing/0001828318-23-000202.md","text":"https://secwatch.observer/filing/0001828318-23-000202.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828318/000182831823000202/0001828318-23-000202-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828318/000182831823000202/envx-20231107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T17:05:10.726592+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9399517d527d62d2fa3a7db56a036a6548238a14","claim":"Enovix Corp reported financial results for third fiscal quarter ended October 1, 2023.","evidence_excerpt":"On November 7, 2023, Enovix Corporation issued a press release announcing the release of its financial results for the third fiscal quarter ended October 1, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1828318/000182831823000202/0001828318-23-000202-index.htm","confidence":0.7,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third fiscal quarter ended October 1, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}